Whole-Body Diffusion-weighted Imaging in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

Whole-Body Diffusion-weighted Imaging in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma

Published:2015-05 Issue:3 Volume:35 Page:747-764
ISSN:0271-5333
Container-title:RadioGraphics
language:en
Short-container-title:RadioGraphics

Author:

Toledano-Massiah Sarah,Luciani Alain,Itti Emmanuel,Zerbib Pierre,Vignaud Alexandre,Belhadj Karim,Baranes Laurence,Haioun Corinne,Lin Chieh,Rahmouni Alain

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rg.2015140145

Reference62 articles.

1. Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

2. Revised Response Criteria for Malignant Lymphoma

3. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.

4. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

5. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Applications of PET/MR: Part II: Clinical Applications II;Canadian Association of Radiologists Journal;2024-06-05

2. Comparison of reduced field-of-view DWI and conventional DWI techniques for the assessment of lumbar bone marrow infiltration in patients with acute leukemia;Frontiers in Oncology;2024-01-08

3. Computed diffusion-weighted imaging with a low-apparent diffusion coefficient-pixel cut-off technique for breast cancer detection;The British Journal of Radiology;2023-11

4. Whole-body diffusion-weighted imaging with background body signal suppression and quantitative apparent diffusion coefficient in the detection, staging, and grading of non-Hodgkin lymphoma;Polish Journal of Radiology;2023

5. Hematologic Cancers;Multimodality Imaging and Intervention in Oncology;2023